Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam

(2437) Views  (357) Full article downloads

Authors: Adeeb Yacoub, Andrew Francis

Published Date February 2006 Volume 2006:2(2) Pages 235 - 240

DOI: http://dx.doi.org/10.2147/NDT.S

Adeeb Yacoub, Andrew Francis

Department of Psychiatry and Behavioral Science, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA

Objective: The authors report three cases of neuroleptic malignant syndrome (NMS) induced by atypical antipsychotics (olanzapine and clozapine) which showed classic features of NMS including muscular rigidity and prominent fever.

Method: Case reports.

Results: A 66-year-old man with dementia and alcohol abuse developed NMS while on olanzapine for agitation and combativeness. A 62-year-old man with schizophrenia developed NMS 6 days after starting clozapine. A 43-year-old man with bipolar disorder developed NMS 14 days after starting clozapine. All three cases showed classic features of NMS including muscular rigidity and fever. Resolution of fever and muscular rigidity occurred within 72 hours with discontinuation of neuroleptics, supportive care, and lorazepam. The NMS rating scale reflected daily clinical improvement.

Conclusion: Classic NMS characterized by muscular rigidity and prominent fever may occur with atypical neuroleptics. Our cases suggest recovery from NMS associated with atypical neuroleptics may be hastened by lorazepam, as was previously reported for NMS from typical neuroleptics. Also, the NMS rating scale was sensitive to clinical improvement.

Keywords: atypical antipsychotics, neuroleptic malignant syndrome, lorazepam, catatonia, rating scale